Randomized, Double-Blind Study of AK1830 in Patients with low back pai
Phase 2
Completed
- Conditions
- ow back pain
- Registration Number
- JPRN-jRCT2080225352
- Lead Sponsor
- Asahi Kasei Pharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Patient with low back pain
Exclusion Criteria
*Patient has renal, hepatic, cardiac, pancreatic, or metabolic diseases or hematologic abnormality.
*Patients with a history or complication of malignancy within 5 years
*Patient who are pregnant or may be pregnant, who wants to be pregnant during the trial period, patients who are nursing. Patient who cannot agree on proper contraception in the patient or the patient's female partner is a pregnant woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method